tiprankstipranks
Advanced Medical Solutions Group PLC (GB:AMS)
LSE:AMS
UK Market
AMS
Advanced Medical Solutions
RESEARCH TOOLSreports

Advanced Medical Solutions (AMS) Share Forecast & Price Target

32 Followers
See the Price Targets and Ratings of:

AMS Analyst Ratings

Moderate Buy
1Ratings
Moderate Buy
1 Buy
0 Hold
0 Sell
Based on 1 analysts giving stock ratings to
Advanced
Medical Solutions
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

AMS Stock 12 Month Forecast

Average Price Target

300.00 p
▲(39.53% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Advanced Medical Solutions in the last 3 months. The average price target is 300.00 p with a high forecast of 300.00 p and a low forecast of 300.00 p. The average price target represents a 39.53% change from the last price of 215.00 p.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"194":"194 p","301":"301 p","220.75":"220.8 p","247.5":"247.5 p","274.25":"274.3 p"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">300.00 p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">300.00 p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":300,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">300.00 p</span>\n  </div></div>","useHTML":true}}],"tickPositions":[194,220.75,247.5,274.25,301],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,211,217.84615384615384,224.69230769230768,231.53846153846155,238.3846153846154,245.23076923076923,252.07692307692307,258.9230769230769,265.7692307692308,272.61538461538464,279.46153846153845,286.3076923076923,293.15384615384613,{"y":300,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,211,217.84615384615384,224.69230769230768,231.53846153846155,238.3846153846154,245.23076923076923,252.07692307692307,258.9230769230769,265.7692307692308,272.61538461538464,279.46153846153845,286.3076923076923,293.15384615384613,{"y":300,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,211,217.84615384615384,224.69230769230768,231.53846153846155,238.3846153846154,245.23076923076923,252.07692307692307,258.9230769230769,265.7692307692308,272.61538461538464,279.46153846153845,286.3076923076923,293.15384615384613,{"y":300,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":212.794,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":212.794,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":195.119,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":209.338,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":222.175,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":196.501,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":202.919,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":209.199,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":200.233,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":204.716,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 48, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":225,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 44, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":218,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":211,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target300.00 pAverage Price Target300.00 pLowest Price Target300.00 p
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Berenberg Bank Analyst forecast on GB:AMS
Unknown Analyst
Berenberg Bank
Not Ranked
Berenberg Bank
300 p
Buy
39.53%
Upside
Reiterated
03/18/26
Advanced Medical Solutions (AMS) Receives a Buy from Berenberg Bank
Peel Hunt Analyst forecast on GB:AMS
Unknown Analyst
Peel Hunt
Not Ranked
Peel Hunt
246 p
Buy
14.42%
Upside
Reiterated
09/17/25
Peel Hunt Reaffirms Their Buy Rating on Advanced Medical Solutions (AMS)
Deutsche Bank Analyst forecast on GB:AMS
Kane Slutzkin
Deutsche Bank
Deutsche Bank
275 p
Buy
27.91%
Upside
Reiterated
07/16/25
Deutsche Bank Keeps Their Buy Rating on Advanced Medical Solutions (AMS)
Stifel Nicolaus Analyst forecast on GB:AMS
Christian Glennie
Stifel Nicolaus
Stifel Nicolaus
245 p
Buy
13.95%
Upside
Upgraded
04/28/25
Stifel Upgrades Advanced Medical Solutions (AMS:LN) to BuyStifel analyst Christian Glennie upgraded Advanced Medical Solutions (AMS:LN) from Hold to Buy with a price target of GBP2.45.
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Berenberg Bank Analyst forecast on GB:AMS
Unknown Analyst
Berenberg Bank
Not Ranked
Berenberg Bank
300 p
Buy
39.53%
Upside
Reiterated
03/18/26
Advanced Medical Solutions (AMS) Receives a Buy from Berenberg Bank
Peel Hunt Analyst forecast on GB:AMS
Unknown Analyst
Peel Hunt
Not Ranked
Peel Hunt
246 p
Buy
14.42%
Upside
Reiterated
09/17/25
Peel Hunt Reaffirms Their Buy Rating on Advanced Medical Solutions (AMS)
Deutsche Bank Analyst forecast on GB:AMS
Kane Slutzkin
Deutsche Bank
Deutsche Bank
275 p
Buy
27.91%
Upside
Reiterated
07/16/25
Deutsche Bank Keeps Their Buy Rating on Advanced Medical Solutions (AMS)
Stifel Nicolaus Analyst forecast on GB:AMS
Christian Glennie
Stifel Nicolaus
Stifel Nicolaus
245 p
Buy
13.95%
Upside
Upgraded
04/28/25
Stifel Upgrades Advanced Medical Solutions (AMS:LN) to BuyStifel analyst Christian Glennie upgraded Advanced Medical Solutions (AMS:LN) from Hold to Buy with a price target of GBP2.45.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Advanced Medical Solutions

3 Months
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+11.50%
upgraded a xxx
 rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +11.50% per trade.
1 Year
Christian GlennieStifel Nicolaus
Success Rate
1/1 ratings generated profit
100%
Average Return
+7.30%
upgraded a buy rating 12 months ago
Copying Christian Glennie's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +7.30% per trade.
2 Years
xxx
Success Rate
1/1 ratings generated profit
100%
Average Return
+7.30%
upgraded a xxx
 rating 12 months ago
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +7.30% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

AMS Analyst Recommendation Trends

Rating
Aug 25
Sep 25
Oct 25
Jan 26
Mar 26
Strong Buy
0
0
0
0
1
Buy
5
5
2
3
1
Hold
26
48
44
27
8
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
31
53
46
30
10
In the current month, AMS has received 2 Buy Ratings, 8 Hold Ratings, and 0 Sell Ratings. AMS average Analyst price target in the past 3 months is 300.00.
Each month's total comprises the sum of three months' worth of ratings.

AMS Financial Forecast

AMS Earnings Forecast

Next quarter’s earnings estimate for AMS is 0.06 p with a range of 0.06 p to 0.06 p. The previous quarter’s EPS was 0.02 p. AMS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year AMS has Performed in-line its overall industry.
Next quarter’s earnings estimate for AMS is 0.06 p with a range of 0.06 p to 0.06 p. The previous quarter’s EPS was 0.02 p. AMS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 56.87% of the time in the same period. In the last calendar year AMS has Performed in-line its overall industry.

AMS Sales Forecast

Next quarter’s sales forecast for AMS is 119.40M with a range of 119.40M to 119.40M . The previous quarter’s sales results were 118.17M . AMS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AMS has Performed in-line its overall industry.
Next quarter’s sales forecast for AMS is 119.40M with a range of 119.40M to 119.40M . The previous quarter’s sales results were 118.17M . AMS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.06% of the time in the same period. In the last calendar year AMS has Performed in-line its overall industry.

AMS Stock Forecast FAQ

What is GB:AMS’s average 12-month price target, according to analysts?
Based on analyst ratings, Advanced Medical Solutions Group PLC’s 12-month average price target is 300.00.
    What is GB:AMS’s upside potential, based on the analysts’ average price target?
    Advanced Medical Solutions Group PLC has 39.53% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Advanced Medical Solutions Group PLC a Buy, Sell or Hold?
          Advanced Medical Solutions Group PLC has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Advanced Medical Solutions Group PLC’s share price target?
            The average share price target for Advanced Medical Solutions Group PLC is 300.00. This is based on 1 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is 300.00 p ,and the lowest forecast is 300.00 p. The average share price target represents 39.53% Increase from the current price of 215 p.
              What do analysts say about Advanced Medical Solutions Group PLC?
              Advanced Medical Solutions Group PLC’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Streets Analysts.
                How can I buy shares of Advanced Medical Solutions Group PLC?
                To buy shares of GB:AMS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.